Journal Club - May 6, 2021
RHAPSODY Trial
Dr. Nav Malhi presented the RHAPSODY Trial, which is a phase 3, multicenter, double-blind, event-driven, randomized-withdrawal trial of rilonacept in patients with acute symptoms of recurrent pericarditis and systemic inflammation. This trial was published in NEJM in January of this year.
